Key result
Transcatheter pulmonary valve placement in patients >40 years was successful in 87% of cases, with significant improvement in functional capacity and a 6% rate of infective endocarditis.
Why the study?
Outcomes of transcatheter pulmonary valve placement (TPV) have been detailed in young patients, but data are limited in older patients.
Does transcatheter pulmonary valve placement improve functional capacity and hemodynamics in patients older than 40 years?
Cohort (n=75)
Yes
Does transcatheter pulmonary valve placement improve functional capacity and hemodynamics in patients older than 40 years?
Answers are grounded in this paper and cite their sources.
Transcatheter pulmonary valve implantation in patients over 40 is safe and effective, yielding significant functional and hemodynamic improvements, though infective endocarditis remains a mid-term risk.
Numerous studies have detailed outcomes of Transcatheter pulmonary valve placement (TPV) in young patients, but there is a paucity of data in older patients. We sought to evaluate short and mid-term outcomes of TPV in patients older than 40 years of age. Retrospective multicenter study of patients older than 40 years at the time of TPV from January 2010 to February 2018. Demographics, procedure details, and follow up data were collected. A total 75 subjects presented for TPV with median age of 49.8 (IQ 45–60). Half of the patients 39 (52%) had evidence of NYHA class III or IV at time of presentation. A total of 65 (87%) had successful TPV. Patients with severe PR had immediate resolution of PI (except for one). Patients with PS had significant improvement in gradient from median of 25.5 to 5.5 mmHg (p < 0.0001). There were no procedure related deaths. Adverse procedural events occurred in 4 (5%) as 2 procedure related arrhythmias and 2 peripheral vascular injuries. The median follow-up was 2 years (IQ 0.74–3.13). Functional capacity has significantly improved in most patients (p < 0.001). There were 4 (6%) non-procedure related mortalities, 2 (3%) pulmonary valve replacement, and 1 (2%) listed for heart transplant. Four patients (6%) experienced infective endocarditis at a median of 23 months from TPV. TPV in patients older than 40 years is safe and effective. Mid-term follow up demonstrates improvement in functional capacity with stable valvular function, however, infective endocarditis occurred in 6%.
No takes yet. Share an insight, caveat, or question.
Aldoss et al. (2021) conducted a cohort in Pulmonary valve disease requiring replacement (n=75). Transcatheter pulmonary valve placement was evaluated on Successful transcatheter pulmonary valve placement. Transcatheter pulmonary valve placement in patients >40 years was successful in 87% of cases, with significant improvement in functional capacity and a 6% rate of infective endocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: